Toshiba will continue offering Vital Images' Vitrea 2 software through subsidiaries and distributors in more than 50 countries under a renewed agreement announced Jan. 9. Toshiba has been offering the software as the 3D medical imaging product of choice
Toshiba will continue offering Vital Images' Vitrea 2 software through subsidiaries and distributors in more than 50 countries under a renewed agreement announced Jan. 9. Toshiba has been offering the software as the 3D medical imaging product of choice to customers purchasing its Aquilion multidetector CTs. The new agreement includes a minimum worldwide revenue commitment from Toshiba of more than $5 million and is effective through Sept. 30, 2003. It can be renewed with the mutual consent of Vital Images and Toshiba.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.